Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.33 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.32 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.32 |
| ▸ | CNR2 | P34972 | 1/20 | 0.31 |
| ▸ | DPP4 | P27487 | 1/20 | 0.31 |
| ▸ | MDH1 | P40925 | 1/20 | 0.31 |
| ▸ | MDH2 | P40926 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30029494 | 0.83 | SCN9A (0.37) | DPP8DPP9ALDH1A1LMNAL3MBTL1 | |
| SCHEMBL525455 | 0.83 | SCN9A (0.37) | DPP8DPP9ALDH1A1LMNAL3MBTL1 | |
| SCHEMBL546868 | 0.82 | TSHR (0.41) | CYP17A1CYP19A1 | |
| SCHEMBL710675 | 0.81 | CYP17A1 (0.34) | CYP17A1CYP19A1 | |
| SCHEMBL32685241 | 0.80 | ALDH1A1 (0.38) | DPP8DPP9ALDH1A1LMNAL3MBTL1 | |
| SCHEMBL1146838 | 0.78 | DPP8 (0.34) | DPP8DPP9ALDH1A1LMNAL3MBTL1 | |
| SCHEMBL1635652 | 0.77 | SCN9A (0.32) | — | |
| SCHEMBL29721445 | 0.77 | SCN9A (0.35) | ALDH1A1L3MBTL1MDH1MDH2 | |
| SCHEMBL30361501 | 0.77 | SCN9A (0.34) | L3MBTL1 | |
| SCHEMBL1635900 | 0.77 | SCN9A (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2293143-B1 | Novel photoresist compositions | ROHM & HAAS ELECT MAT (US) | 2015-09-02 | — | — | EP | disclosed |
| EP-2293143-A2 | Novel resins and photoresist compositions comprising the same | Rohm and Haas Electronic Materials, L.L.C. (US) | 2011-03-09 | — | — | EP | disclosed |
| US-20110039206-A1 | NOVEL RESINS AND PHOTORESIST COMPOSITIONS COMPRISING SAME | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2011-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110039206-A1 | NOVEL RESINS AND PHOTORESIST COMPOSITIONS COMPRISING SAME | PUF60, CAD, RARA | DPP8 4433/4885DPP9 4410/4885ALDH1A1 2478/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.